Comparative analysis of swine leukocyte antigen gene diversity in Göttingen Minipigs.
Sus scrofa
animal model
biomedical research and development
polymorphism
swine leukocyte antigen (SLA)
transplantation
xenograft
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
22
12
2023
accepted:
13
02
2024
medline:
12
3
2024
pubmed:
12
3
2024
entrez:
12
3
2024
Statut:
epublish
Résumé
Worldwide, pigs represent economically important farm animals, also representing a preferred preclinical large animal model for biomedical studies. The need for swine leukocyte antigen (SLA) typing is increasing with the expanded use of pigs in translational research, infection studies, and for veterinary vaccine design. Göttingen Minipigs (GMP) attract increasing attention as valuable model for pharmacological studies and transplantation research. This study represents a first-time assessment of the SLA gene diversity in Göttingen Minipigs in combination with a comparative metadata analysis with commercial pig lines. As Göttingen Minipigs could harbor private as well as potential novel SLA allele combinations, future research projects would benefit from the characterization of their SLA background. In 209 Göttingen Minipigs, SLA class I (
Identifiants
pubmed: 38469309
doi: 10.3389/fimmu.2024.1360022
pmc: PMC10925748
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1360022Informations de copyright
Copyright © 2024 Hammer, Duckova, Gociman, Groiss, Pernold, Hacker, Kasper, Sprung, Stadler, Jensen, Saalmüller, Wenzel and Figueiredo.
Déclaration de conflit d'intérêts
Author LK was employed by the company Merck Healthcare KGaA. Author AJ was employed by the company Ellegaard Göttingen Minipigs A/S. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.